El sistema, probado en un estudio piloto, detectó nueve de cada diez tumores en estadios 0 y I, frente a uno de cada diez con ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results